Lotame Solutions, Inc. – Trademark Portfolio
Entity Type: 03
Lotame Solutions, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LOTAME. The owner is based in Columbia, MD.
8850 Stanford Blvd., Suite 2000
Columbia, MD 21045
Showing of trademarks Trademarks
Trademark Classifications
Lotame Solutions, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Lotame Solutions, Inc. have?
Lotame Solutions, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned, 4 cancelled.
What trademark classes does Lotame Solutions, Inc. file in?
Lotame Solutions, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Lotame Solutions, Inc.'s most well-known trademarks?
Lotame Solutions, Inc.'s registered trademark portfolio includes well-known marks such as LOTAME. These are among 3 currently registered trademarks in the portfolio.
What is Lotame Solutions, Inc.'s trademark registration success rate?
Lotame Solutions, Inc. has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.